insights_auto
Why is GALT down 2.87%?
Dive Deeperchevron_right
GALT:NASDAQ
Galectin Therapeutics Inc. Common Stock
$3.05
arrow_downward
-2.87%(-0.090) 1D
Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GALT...
Open
$3.16
High
$3.31
Low
$2.93
Mkt. cap
307.59M
Avg. vol.
204.32K
Volume
181.59K
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.53
Shares outstanding
100.85M
No. of employees
9
Open
$3.16
High
$3.31
Low
$2.93
Mkt. cap
307.59M
Avg. vol.
204.32K
Volume
181.59K
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.53
Shares outstanding
100.85M
No. of employees
9
News stories
From web sources and news partners
BigGo Finance
·
12 hours ago
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
The Motley Fool
·
7 hours ago
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
TradingView
·
17 hours ago
Key facts: Tesla Merger Talks; $29,990 Cybercab Offer; S&P 500 Impact
StoneX
·
2 days ago
S&P 500, Nasdaq 100 Claw Back But NVDA Cloud Looms Overhead
About Galectin Therapeutics Inc. Common Stock
CEO-
Employees9
Founded2000
HeadquartersNorcross, Georgia, United States
SectorHealth Care
IndustryBiotechnology
Websitegalectintherapeutics.com